US equities |
NVDA $239.79 ▲+2.50% SPCX $169.37 ▲+6.55% MU $1,060.83 ▼-1.31% TSLA $380.80 ▲+2.75% SNDK $1,692.28 ▼-1.61% MSFT $528.31 ▲+2.08% INTC $116.38 ▼-2.47% META $743.08 ▲+2.06%
FinancialContent

Articles published by Arrowhead Pharmaceuticals

News headline image
Arrowhead Pharmaceuticals Files CTA for Investigational ARO-DIMER-PA – the First Dual Functional RNAi Therapeutic for the Treatment of Mixed Hyperlipidemia
From Arrowhead Pharmaceuticals
Via Business Wire
Tickers ARWR